These novel therapies , Tirzepatide , represent a significant advancement in managing metabolic dysfunction and possibly other ailments . They all are categorized as GLP-1 receptor agonists , indicating https://lilliomtf621677.azzablog.com/41784977/retatrutide-a-thorough-exploration-into-metabolic-copyright